Login / Signup
Editorial: similar risk of hepatocellar carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe.
Pietro Lampertico
Georgios Papatheodoridis
Published in:
Alimentary pharmacology & therapeutics (2021)
Keyphrases
</>
hepatitis b virus
antiretroviral therapy
liver fibrosis